Anne Stössel

Synthesis of cyclopamine using a biomimetic and diastereoselective approach.

A. Giannis, P. Heretsch, V. Sarli, 2009, Angewandte Chemie.

Structure-Based Design and Discovery of New M2 Receptor Agonists.

B. Shoichet, A. Christopoulos, R. Sunahara, 2017, Journal of medicinal chemistry.

Structure-Based Design and Discovery of New M2 Receptor Agonists.

B. Shoichet, A. Christopoulos, R. Sunahara, 2017, Journal of medicinal chemistry.

The soluble guanylyl cyclase inhibitor NS-2028 reduces vascular endothelial growth factor-induced angiogenesis and permeability.

C. Roussos, A. Papapetropoulos, A. Pyriochou, 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

The experimental power of FR900359 to study Gq-regulated biological processes

H. Dohlman, C. Müller, M. Hesse, 2015, Nature Communications.

Development of molecular tools based on the dopamine D3 receptor ligand FAUC 329 showing inhibiting effects on drug and food maintained behavior.

P. Gmeiner, O. Prante, H. Hübner, 2017, Bioorganic & medicinal chemistry.

An allosteric modulator binds to a conformational hub in the β2 adrenergic receptor

B. Shoichet, R. Sunahara, B. Kobilka, 2020, Nature Chemical Biology.

Dual targeting of adenosine A(2A) receptors and monoamine oxidase B by 4H-3,1-benzothiazin-4-ones.

Sonja Hinz, Michael Gütschow, C. Müller, 2013, Journal of medicinal chemistry.

Synthesis and biological evaluation of oxadiazole derivatives as inhibitors of soluble guanylyl cyclase.

A. Papapetropoulos, A. Pyriochou, A. Giannis, 2010, Bioorganic & medicinal chemistry.

Constrained catecholamines gain β2AR selectivity through allosteric effects on pocket dynamics

A. Venkatakrishnan, R. Sunahara, B. Kobilka, 2023, Nature communications.